UC San Diego Start-Up Emotient Shows the Face of New Technology
The start-up Emotient is a prime example of how industry, academia, and venture capital can combine to create a groundbreaking business.
The start-up Emotient is a prime example of how industry, academia, and venture capital can combine to create a groundbreaking business.
Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse: Amanda was experiencing heart failure. She was quickly transferred to UC San Diego Sulpizio Cardiovascular Center where a multidisciplinary team implanted a novel cardiac device under her skin, leaving the heart untouched, to prevent sudden cardiac arrest.
The term ‘selfie’ took on a life of its own in 2013, especially after the Oxford English Dictionary selected it as the ‘international word of the year’. The Internet and mobile phones were awash in self-portraits as consumers purchased more smartphones with front-facing cameras – turning the selfie into a truly worldwide phenomenon. Now comes more evidence that selfies have come to inhabit a unique place in world culture – a place with a Web address of its own: Selfiecity.net.
Supported by a $953,958 grant from the Defense Advanced Research Projects Agency (DARPA), researchers at the University of California San Diego will develop a sophisticated new biosensor that can protect the nation’s water supplies from a wide range of toxins, including heavy metals and other poisons.
The 2015 edition of the U.S. News & World Report’s Best Graduate Schools guidebook, released today, highly ranks the University of California, San Diego’s professional schools in engineering and medicine, as well as its academic Ph.D. programs in the sciences.
Identify a real-world problem. Engineer a solution. And, if the solution works, figure out how it can be commercially viable. That’s what Michael Benchimol said he learned over 7 years of working in the laboratory of Sadik Esener, a professor in the departments of NanoEngineering and Electrical and Computer Engineering at the University of California, San Diego. In Benchimol’s (Ph.D., Electrical Engineering, ’12) case, it specifically means building a company to advance a targeted drug delivery platform that could make chemotherapy more effective and less toxic to the healthy tissue in the body.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.